Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalya Khodeneva

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|February 16, 2023
Melanocortin therapies to resolve fibroblast-mediated diseasesNatalya Khodeneva, Michelle A Sugimoto, Camilla S A Davan-Wetton, et al.
Current Topics in Microbiology and Immunology|May 18, 2026
Resolution Pharmacology Targeting the Melanocortin SystemNicholas J Day, Camilla S A Davan-Wetton, Natalya Khodeneva, et al.
Scientific Reports|June 11, 2026
The anti-inflammatory efficacy of melanocortin drugs is influenced by genetic variation at MC1RNatalya Khodeneva, Camilla S A Davan-Wetton, Thomas E N Jonassen, et al.
Arthritis Research & Therapy|October 1, 2025
The senescence-like activity of BMS-470539 is associated with anti-fibrotic actions in models of dermal fibrosisCamilla Sa Davan-Wetton, Natalya Khodeneva, Christopher P Denton, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|February 16, 2023
Melanocortin therapies to resolve fibroblast-mediated diseasesNatalya Khodeneva, Michelle A Sugimoto, Camilla S A Davan-Wetton, et al.
Current Topics in Microbiology and Immunology|May 18, 2026
Resolution Pharmacology Targeting the Melanocortin SystemNicholas J Day, Camilla S A Davan-Wetton, Natalya Khodeneva, et al.
Scientific Reports|June 11, 2026
The anti-inflammatory efficacy of melanocortin drugs is influenced by genetic variation at MC1RNatalya Khodeneva, Camilla S A Davan-Wetton, Thomas E N Jonassen, et al.
Arthritis Research & Therapy|October 1, 2025
The senescence-like activity of BMS-470539 is associated with anti-fibrotic actions in models of dermal fibrosisCamilla Sa Davan-Wetton, Natalya Khodeneva, Christopher P Denton, et al.
Pageof 1